Skip to content

Multiparametric Characterization of Colorectal Cancers (METRAD)

Multiparametric Characterization of Colorectal Cancers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07000474
Acronym
METRAD
Enrollment
200
Registered
2025-06-03
Start date
2025-03-01
Completion date
2026-12-31
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal Cancer

Keywords

colon cancer, rectal cancer, radiomics

Brief summary

The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).

Detailed description

Around 20% of patients with colorectal cancer present with synchronous liver metastases at the time of diagnosis. In recent years, there has been increasing interest in the high-throughput extraction of quantitative data from medical images, a technique known as radiomics. Radiomic analysis can involve both qualitative and quantitative imaging parameters, which may be used independently or integrated into multiparametric prediction models. This is a multicenter, retrospective study designed to investigate the demographic, clinical, and radiological features, treatment regimens, and outcomes of patients diagnosed with colorectal cancer. The study will involve the collection of anonymized clinical data, including age, sex, diagnosis date, treatment details, results from histopathological and genetic analyses, as well as pre- and post-treatment medical imaging typically performed as part of the management of colorectal cancer patients, along with survival and tumor recurrence data. PRIMARY EVALUATION CRITERIA Prediction of recurrence/treatment response based on the radiomic model. SECONDARY EVALUATION CRITERIA The impact of CT scan image acquisition and reconstruction parameters on the prognostic model.

Interventions

OTHEROmics

Multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients who have undergone surgery for colorectal cancer.

Exclusion criteria

* Patients under legal protection (guardianship, curatorship, etc.) * Refusal to participate (expressed opposition) * Individuals with conditions that could interfere with the study protocol or impact data integrity

Design outcomes

Primary

MeasureTime frameDescription
survival predictive model2 yearsThe primary objective is to evaluate the predictive value of a model built through multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026